Epikast
Brooklyn, US · Founded 2022 · Delaware corporation · 2 known investors
Epikast provides medically trained talent and AI-driven engagement tools to biopharma and healthcare organizations for communicating with healthcare professionals and patients across the US and Europe. The company combines peer-to-peer engagement models, medical expertise, and proprietary AI insights to reduce costs and improve stakeholder outreach.
AI & Machine LearningHealthtech
Founders & leadership
EV
Evangelos VergetisExecutive Officer, Director
ON
Oleg NodelmanDirector
BP
Brad ProsekDirector
SP
Stelios PapadopoulosDirector
DK
Daphne KarydasDirector
AT
Alexandros TzoukasDirector
DP
Dimitrios PapalexopoulosDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$700KraisedFeb 2026 · 2 investors · Other Health CareRule 506(b)
▶$700KraisedFeb 2026 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brad ProsekDirector
- Evangelos VergetisExecutive Officer, Director
- Oleg NodelmanDirector
- Stelios PapadopoulosDirector
- Daphne KarydasDirector
- Alexandros TzoukasDirector
- Dimitrios PapalexopoulosDirector
- Offering amount
- $2.2M
- Amount sold
- $700K
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$5MraisedFeb 2023 · 2 investors · Other Health CareRule 506(b)
▶$5MraisedFeb 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Evangelos VergetisExecutive Officer, Director
- Stelios PapadopoulosDirector
- Offering amount
- $10M
- Amount sold
- $5M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.